With Preliminary Win for DOAC, Sights Set on Supplanting DAPT After LAA Closure

(MedPage Today) -- PARIS -- In the first randomized trial of antithrombotic therapy after successful left atrial appendage (LAA) occlusion, low-dose apixaban (Eliquis) provided the better balance of thrombotic and bleeding events compared with...

Source: MedPage Today Neurology - May 18, 2023 Category: Neurology Source Type: news